Geftinat 250mg Gefitinib Tablets

Geftinat 250mg Gefitinib Tablets

Geftinat is a potent anticancer medicine that comes under class of tyrosine kinase inhibitor. It effectively targets and inhibits epidermal growth factor receptor (EGFR) mutations, offering a targeted therapy for certain types of non-small cell lung cancer (NSCLC). 

  • Manufactured Products :Natco Pharma Ltd
  • Salt composition :Gefitinib 250mg

 

Category: Tag:

Medicine 

Geftinat 250mg

Manufacturer

Natco Pharma Ltd

Active Ingredient 

Gefitinib (250mg)

Storage

Store below 30°C

Consume Type 

Oral

Description – 

Complete Handbook on Geftinat: Usage and Insight 

Geftinat 250mg  – Introduction

Geftinat 250mg Tablet is prescribed for treating non-small cell lung cancer. This medication is specifically intended for patients whose cancer has metastasized to different body parts, individuals with unusual epidermal growth factor receptor (EGFR) genes, and those who have not undergone any prior cancer treatments.

How Geftinat 250mg Works: A Closer Look

Geftinat, a 250mg Tablet, is classified as an anti-cancer drug. It prevents the irregular protein activity that triggers cancer cells to proliferate and divide. Consequently, this drug successfully stops or slows the spread of cancer cells.

Geftinat 250mg Use

Non-small cell lung cancer

Geftinat 250mg – The Benefits 

Non-small cell lung cancer is a prevalent cancer that impacts individuals, whether smokers or non-smokers. Geftinat 250mg tablet, is used as a stand-alone treatment or in combination with other drugs to treat non-small cell lung cancer. Given the strength and potential for toxicity of this medicine, it is imperative that you thoroughly examine the benefits and dangers with your healthcare professional. You should avoid alcohol during this treatment and be adequately hydrated by drinking lots of water.

Geftinat 250mg – A Usage Guide

Follow your doctor’s instructions regarding the dosage and duration of this medication. Ingest the tablet whole; do not chew, crush, or break it. Geftinat 250mg Tablet can be consumed with or without food, although it’s advisable to take it consistently at the same time.

Geftinat 250mg – Side Effects

The majority of side effects typically do not necessitate immediate medical intervention and tend to resolve as your body acclimates to the medication. However, if these side effects persist or cause you concern, it is advisable to seek advice from your doctor.

Common Side Effects 

  • Diarrhea
  • Dry skin
  • Loss of appetite
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Vomiting
  • Weakness
  • Weight loss

 

[Note: Different drugs can cause varying side effects. To get accurate information about a medication’s specific side effects, refer to the official prescribing information for that medication or consult with your healthcare provider.]

Geftinat 250mg- A Guide to Safety 

Alcohol

Unsafe

Drinking alcohol while taking a Geftinat 250mg tablet is not advised.

Pregnancy

Consult Your Doctor 

It is not recommended to take the Geftinat 250mg pill while pregnant because there is clear evidence that it may harm the growing fetus. If the benefits outweigh the risks, the doctor may very seldom prescribe it if there is a death threat. Please consult your physician.

Breastfeeding

Consult Your Doctor

Using Geftinat, a 250 mg tablet, during nursing is most likely not advised. According to scant human data, the medication may damage the unborn child if it enters the breast milk.

Driving

Unsafe

You may get adverse effects with the Geftinat 250mg Tablet that could impair your driving ability.

Liver 

Safe If Prescribed

In individuals with severe kidney illness, the usage of Geftinat 250mg Tablet should be done with caution. It could be necessary to modify the dosage of Geftinat 250mg Tablet. Kindly speak with your physician.

Kidney 

Caution

Patients with liver disease can probably safely take Geftinat 250 mg tablets. Based on limited data, changing the dosage of Geftinat 250mg Tablet may not be necessary for these patients. Kindly speak with your physician.

Fact Box

Chemical Group Quinazolinamines
Addictive No
Medication ClassANTINEOPLASTICS
Action Class/Category Tyrosine kinase inhibitors

Swift Advice

  • Geftinat 250mg Tablet is prescribed for locally advanced or metastatic non-small cell lung cancer.
  • It can be taken with or without food, ideally at the same time daily.
  • Avoid using antacids within 2 hours before or 1 hour after taking this medication.
  • Diarrhea is a potential side effect; if it persists or you notice blood in your stools, inform your doctor.
  • Practice reliable contraception during treatment and one month after discontinuing the medicine to prevent pregnancy.
  • Notify your healthcare provider if you experience mouth ulcers, vision changes, worsening cough, shortness of breath, or breathing issues while on this medication.
  • Your doctor may recommend regular liver function tests during your treatment with this medicine.

Frequently Asked Questions – Geftinat 250mg

Q1. How long does lung cancer take to spread?

Most forms of lung cancer typically take three to six months to double in size. Lung cancer requires many years to grow to a stage where an X-ray could be used to diagnose it.

Q2. What are lung cancer’s early warning signs?

A persistent cough that worsens over time is the most common indicator of lung cancer. A patient may occasionally observe blood in their cough. Lung cancer is also indicated by coughing and chest pain.

Q3. When taking 250 mg pills of Geftinat, what should I avoid?

You should wait two hours before or one hour after taking a Geftinat 250mg tablet before taking an antacid or medication that reduces stomach acid.